Cuéllar-Garduño N

Idioma: Español
Referencias bibliográficas: 25
Paginas: 135-138
Archivo PDF: 99.65 Kb.

FRAGMENTO

La citorreducción quirúrgica (CRQ) combinada con la administración de quimioterapia intraperitoneal hipertérmica (HIPEC, del inglés heated intraperitoneal chemotherapy) se ha desarrollado en los últimos años como una técnica efectiva para el tratamiento de tumores malignos en la superficie peritoneal, los cuales son catalogados en general como carcinomatosis peritoneal y tienen su origen en tumores abdominales ginecológicos y no ginecológicos (con mayor frecuencia cáncer de ovario, gástrico, de colon y recto), pseudomixoma peritoneal y tumores primarios de peritoneo. Debe considerarse un procedimiento complejo, con un riesgo cardíaco elevado y no exento de complicaciones.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Webb CA, Weyker PD, Moitira VK, Raker RK. An Overview of Cytorreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for the Anesthesiologist. Anesth Analg. 2013;116:924-31.

2. Raspe C, Piso P, Wiesenack C, Bucher M. Anesthetic Management in patients undergoing hyperthermic chemotherapy. Curr Opin Anesthesiol. 2012;25:348-355.

3. Crowley K, Pitroff A, Adkinsson G, Esquivel J. Anesthetic Considerations for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Available: www.hipec.org/Literature.html

4. Piso P, Glockzin G, von Breitenbuch P, et al. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies. J Surg Oncol. 2009;100:317-20.

5. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29-42.

6. Ahmed S, Oropello J. Critical Care Issues in Oncological Surgery Patients. Crit Care Clin. 2010;26:93-106.

7. Esquivel J. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea. Cancer J. 2009;15:249-54.

8. Esquivel J, Angulo F, Bland RK, et al. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open “coliseum technique”. Ann Surg Oncol. 2000;7:296-300.

9. Schmidt C, Creutzenberg M, Piso P, et al. Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia.2008;63:389-95.

10. Chu DZ, Lang NP, Thompson C, et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63:364-67.

11. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-43.

12. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology. 2000;58:96-107.

13. Vanacker B. Anaesthetic issues in women undergoing gynaecological cytoreductive surgery. Curr Op Anaesth. 2009;22:362-367.

14. López-Berlanga L, De Miguel A, Elvira A. Experiencia en la anestesia y cuidados postoperatorios de 11 casos de peritonectomía y quimioterapia intraperitoneal caliente. Rev Esp Anestesiol Reanim. 2004;51:423-428.

15. Rothfield KP, Crowley K. Anesthesia Considerations During Cytoreductive Surgery and Hypertermic Intraperitoneal Chemotherapy. Surg Oncol Clin NA. 2012;21:533-541.

16. Poise Study group. Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008;371:1839-1847.

17. Boushra NN, Muntazar M. The role of statins in reducing perioperative cardiac risk-physiological and clinical perspectives. Can J Anaesth. 2006;53:1126-1147.

18. Fleisher LA. Should Beta-adrenergic blocking agents be given routinely in noncardiac surgery? In: Fleisher LA (ed). Evidence-Based Practice of Anesthesiology. Philadelphia: Elsevier: 2004. pp. 163-167.

19. Fleischmann KE, Beckman JA, Buller CE, et al. 2009 ACC/AHA focused update on perioperative beta blockade: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120: 2123-51.

20. Schmidt C, Moritz S, Rath S, et al. Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis. J Surg Oncol. 2009;100:297-301.

21. Van Leeuwen BL, Graf W, Pahlman L, et al. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol. 2008;15:745-53.

22. Bijelic L, Jonson A, Sugarbaker PH. Systemic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol. 2007;18:1943-50.

23. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727-31.

24. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77:2622-29.

25. Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, peri-operative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.